CEVA Logistics' acquisition of Fagioli Group enhances its end-to-end logistics capabilities, integrating Fagioli's expertise ...

In today’s Pharma Pulse, Novartis and Moderna anchor a domestic manufacturing surge, while AI-driven biomarker discovery and ...

Major regulatory developments—including the Medicare MFP program, the introduction of the 340B rebate, changes to the MDRP, and updates to the physician fee schedule—are reshaping commercial ...

Pharmacy benefit managers (PBMs) significantly impact GTN revenue through rebates, but patient access issues persist due to ...

Cheryl Allen, BS Pharm, MBA, founding partner, highlights the coming year's focus on navigating an evolving regulatory ...

In today’s Pharma Pulse, SOBI strengthens its gout franchise by acquiring Arthrosi Therapeutics for up to $1.5 billion, ...

In mid-November, to boost domestic drug product manufacturing of its own, Moderna announced 3 a new $140 million investment ...

The evolution from time-consuming manual reviews to automated detection and now to intelligent action is reimagining the ...

Modern PBMs, or PBM-like functions, should operate with full line-of-sight to net price and patient outcomes. Full ...

Although he typically revises his macro framework only once every decade or more, Roth explained that the current environment ...

At a time when investors are questioning the sustainability of pharmaceutical business models, reliable execution has become ...

One of which revolved around “Optimizing GTN Strategy—Balancing Channel Economics and Market Access,” led by Lannett ...